Publisher's Synopsis
Alzheimer's and Parkinson's diseases are the most frequent age-related neurodegenerative diseases, and have similarities in etiology, in clinical and pathological features, and in drug development strategies like the neurotransmitter-supplementation therapy. This second of a two-volume proceedings o